Poseida Therapeutics Inc (PSTX)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 116.31M | 10.05M | 10.34M | 20.01M | 9.35M | 25M | 28.14M | 25.97M |
営業利益 | 71.78M | -33.22M | -39.52M | -27.86M | -36.22M | -25.91M | -24.58M | -31.76M |
税引前収入 | 70.66M | -33.03M | -38.85M | -27.46M | -31.67M | -25.35M | -24.27M | -31.37M |
純利益 | 70.41M | -33.32M | -38.85M | -27.46M | -31.78M | -25.35M | -24.27M | -31.37M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 72.44M | -31.05M | -36.82M | -25.32M | -29.44M | -23.08M | -22.02M | -29.11M |
EBITDA | 73.13M | -31.87M | -38.19M | -26.45M | -34.78M | -24.47M | -23.2M | -30.41M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 31.24M | 130.49M | 64.7M |
営業利益 | -41.99M | -85.53M | -126.55M | -141.41M | -59.95M | -129.5M |
税引前収入 | -44.61M | -86.53M | -129.78M | -124.97M | -63.46M | -123.32M |
純利益 | -44.4M | -86.53M | -129.78M | -124.97M | -64M | -123.43M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.901 | -5.258 | -2.098 | -1.999 | -0.745 | -1.291 |
EBIT | -42.81M | -82.97M | -126.27M | -121.62M | -57.09M | -114.65M |
EBITDA | -41.3M | -84.34M | -123.96M | -136.86M | -54.77M | -123.89M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約